TY  - GEN
AU  - Yao,Song
AU  - Barlow,William E
AU  - Albain,Kathy S
AU  - Choi,Ji-Yeob
AU  - Zhao,Hua
AU  - Livingston,Robert B
AU  - Davis,Warren
AU  - Rae,James M
AU  - Yeh,I-Tien
AU  - Hutchins,Laura F
AU  - Ravdin,Peter M
AU  - Martino,Silvana
AU  - Lyss,Alan P
AU  - Osborne,C Kent
AU  - Abeloff,Martin
AU  - Hortobagyi,Gabriel N
AU  - Hayes,Daniel F
AU  - Ambrosone,Christine B
TI  - Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer
SN  - 1557-3265
PY  - 2011///0404
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Algorithms
KW  - Antineoplastic Agents, Alkylating
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Carcinoma
KW  - Cyclophosphamide
KW  - Cytochrome P-450 CYP2B6
KW  - Cytochrome P-450 CYP3A
KW  - Disease-Free Survival
KW  - Female
KW  - Glutathione S-Transferase pi
KW  - Glutathione Transferase
KW  - Humans
KW  - Inactivation, Metabolic
KW  - Metabolic Networks and Pathways
KW  - Middle Aged
KW  - North America
KW  - Oxidoreductases, N-Demethylating
KW  - Polymorphism, Genetic
KW  - physiology
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1158/1078-0432.CCR-10-0281
ER  -